Skip to main content
NoomLaunch

Noom Health's SmartRx program on track to cut employer's GLP-1 spend by nearly 80%.

What happened

Noom Inc. launches Metabolic Suite.

Source

Article excerpt

Noom Health's SmartRx program on track to cut employer's GLP-1 spend by nearly 80%. Apr 23, 2026 | Last updated Apr 23, 2026 Source references. Early data from first participating employer show that SmartRx can save organizations millions by bypassing traditional pbms to deliver brand-name GLP-1 medications. NEW YORK, April 23, 2026 - Noom Health, the enterprise division of the leading behavior change platform Noom, today announced that its Smart[Rx] program is on pace to cut GLP-1 medication costs by nearly 80% for its first participating employer, projecting approximately $1.3M in annual spend compared to $6.2M in the prior year. Program integration began in January 2026 with these early results pointing to a huge savings opportunity for other organizations grappling with runaway anti-obesity medication expenses. This data offers meaningful proof that a structured, clinically integrated GLP-1 strategy can deliver millions in real savings without compromising access or member outcomes.* Employer health strategies have traditionally centered on condition-specific programs to manage diseases like obesity, diabetes, and cardiovascular conditions individually, which has led to employers managing multiple point solutions simultaneously, often with low coordination, engagement, and return on investment. GLP-1 medications have rapidly accelerated this challenge, becoming one...

Keep reading with a free account

The rest of this article, and every signal for Noom, is in your free account.

Extracted from this sentence

Noom Health developed its Metabolic Suite offering to address this integration opportunity.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
Metabolic Suite

The full record

From the Signal API record

Details

Category
Launches

Extraction

Confidence
46%
Detected
Apr 23, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for Noom and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Noom this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2a2c40e6-9c6b-4e35-8c0e-5a873c6be123 returns this record as JSON. POST /v1/companies/enrich returns every signal for noom.com.

{
  "signal_id": "2a2c40e6-9c6b-4e35-8c0e-5a873c6be123",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-04-23T00:00:00+00:00",
  "company": {
    "name": "Noom",
    "domain": "noom.com"
  },
  "data": {
    "url": "https://www.noom.com/in-the-news/smartrx-glp1-employer-savings",
    "title": "Noom Health's SmartRx program on track to cut employer's GLP-1 spend by nearly 80%.",
    "excerpt": "Noom Health's SmartRx program on track to cut employer's GLP-1 spend by nearly 80%.\n\nApr 23, 2026 | Last updated Apr 23, 2026\n\nSource references.\n\nEarly data from first participating employer show that SmartRx can save organizations millions by bypassing traditional pbms to deliver brand-name GLP-1 medications.\n\nNEW YORK, April 23, 2026 - Noom Health, the enterprise division of the leading behavior change platform Noom, today announced that its Smart[Rx] program is on pace to cut GLP-1 medication costs by nearly 80% for its first participating employer, projecting approximately $1.3M in annual spend compared to $6.2M in the prior year.\n\nProgram integration began in January 2026 with these early results pointing to a huge savings opportunity for other organizations grappling with runaway anti-obesity medication expenses. This data offers meaningful proof that a structured, clinically integrated GLP-1 strategy can deliver millions in real savings without compromising access or member outcomes.*\n\nEmployer health strategies have traditionally centered on condition-specific programs to manage diseases like obesity, diabetes, and cardiovascular conditions individually, which has led to employers managing multiple point solutions simultaneously, often with low coordination, engagement, and return on investment. GLP-1 medications have rapidly accelerated this challenge, becoming one...",
    "product": "Metabolic Suite",
    "summary": "Noom Inc. launches Metabolic Suite.",
    "category": "launches",
    "found_at": "2026-04-23T00:00:00Z",
    "planning": false,
    "image_url": "https://www.noom.com/tachyon/2026/04/noom-health-logo-scaled.jpg",
    "confidence": 0.4566,
    "product_data": {
      "full_text": "Metabolic Suite",
      "fuzzy_match": true
    },
    "published_at": "2026-04-23T00:00:00Z",
    "article_sentence": "Noom Health developed its Metabolic Suite offering to address this integration opportunity."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.